deltatrials
Terminated NA NCT00958711

The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer

Sponsor: Baxter Healthcare Corporation

Conditions Diabetic Foot Ulcers
Interventions Saline and Gauze Unite Biomatrix
Updated 7 times since 2017 Last updated: Dec 3, 2019 Started: Jan 31, 2009 Primary completion: May 31, 2012 Completion: May 31, 2012

A NA clinical study on Diabetic Foot Ulcers, this trial is terminated or withdrawn. The trial is conducted by Baxter Healthcare Corporation and has accumulated 7 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Dec 2021 — Jul 2024 [monthly]

    Terminated NA

  4. Jan 2021 — Dec 2021 [monthly]

    Terminated NA

  5. Jan 2020 — Jan 2021 [monthly]

    Terminated NA

▶ Show 2 earlier versions

  1. Jun 2018 — Jan 2020 [monthly]

    Terminated NA

  2. Jan 2017 — Jun 2018 [monthly]

    Terminated NA

    First recorded

Jan 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Baxter Healthcare Corporation
  • Synovis Surgical Innovations
Data source: Baxter Healthcare Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Evans, United States
  • • Greenville, United States
  • • Kinston, United States
  • • Miami, United States
  • • Rocky Mount, United States
  • • San Diego, United States
  • • Springfield, United States
  • • York, United States